Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial

• Conditions: Proteinuria; HBVe-antigen

• Registration Number: NCT01152060
• Lead Sponsor: Nanchang University

Brief Summary

Lamivudine treatment for HBV-DNA negative HBV-GN patients.

Detailed Description

lamivudine and predinisone treatment for HBV-DNA negative HBV-GN patients.

Study Timeline

• Study Start: 2010-01
• Status Verified: 2010-05
• Study First Submitted: 2010-06-28
• Study First Submitted QC: 2010-06-28
• Last Update Submitted: 2010-06-28
• Study First Posted: 2010-06-29
• Last Update Posted: 2010-06-29
• Primary Completion: 2010-11
• Study Completion: 2010-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Adult HBV-GN patients with biopsy-proven MN, heavy protinuria, HBsAg or HBeAg positive, HBV-DNA negative

Exclusion Criteria

• Primary MN patients, HBV-DNA positive

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified